Irrus Investments' Portfolio

CroíValve has developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation.

Deciphex is developing digital pathology software applications, for clinical and toxicologic pathology, that improve productivity and help pathologists focus on the critical content.

HookeBio - The company specializes in microfluidic technology development for high throughput combinatorial drug screening.

Longboat Clinical - In the complex world of clinical development, Longboat's cloud-based site and patient engagement platform empowers clinical trial site staff and patients to do the right thing at the right time, from patient recruitment through to study closeout.

AventaMed develops innovative medical devices which simplify surgery, allowing procedures to move out of the Operating Room and into new sites of service, such as the clinic or doctor’s office.

Nexvet, a biologic therapeutics company, develop a pipeline of monoclonal antibody (mAb) therapies for companion animals in pain and other therapeutic areas.

Sublimity Therapeutics / Sigmoid’s goal is to identify and create meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases and disorders.